COMMUNIQUÉS West-GlobeNewswire

Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants

14/10/2024 - 19:45

Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]

Inventiva annonce la mise à disposition d'un prospectus dans le cadre de son financement par l’émission d’actions ordinaires et de bons de souscription d’action préfinancés

14/10/2024 - 19:45

Daix (France), Long Island City (New York, États-Unis), le 14 octobre 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]

Norton Healthcare acquires groundbreaking focused ultrasound technology

14/10/2024 - 19:26

Norton Neuroscience Institute first in Kentucky with incisionless surgery for essential tremor, tremor-dominant Parkinson’s disease LOUISVILLE, Ky., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Norton Neuroscience Institute is the [...]

Ipsen receives its second Shingo Prize for operational excellence

14/10/2024 - 18:00

Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patients Ipsen’s first Shingo Prize was received by its production site in Signes, France in 2020, followed [...]

Ipsen reçoit un deuxième prix Shingo pour son excellence opérationnelle

14/10/2024 - 18:00

Ipsen est la première société pharmaceutique au monde à avoir reçu le prix Shingo pour deux sites de production de médicaments destinés aux patients. Ipsen a reçu son premier prix Shingo pour son site de production de [...]

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical

14/10/2024 - 16:43

TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) hereby announces that it has entered into a debt-for-equity swap agreement (the " Debt Swap Agreement ") [...]

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

14/10/2024 - 16:30

First Phase 3 PDT study in patients with sBCC in the United States. Rigorous dual endpoints requiring complete clinical and cytological clearance of malignant lesions. Data now being analyzed, interim results expected [...]

Cookie Diet announces the launch of new Four-Week Program

14/10/2024 - 16:20

America's most convenient diet revealed: These famous weight-loss cookies make it easy to shred kilos AND there’s a money-back guarantee. SYDNEY, Australia, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Dr Siegal’s famous Cookie [...]

Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology

14/10/2024 - 15:45

PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

You’re Invited! WonderTree’s Innovative, Team-Based Clinic to Celebrate Grand Opening

14/10/2024 - 15:30

On Friday, October 18, WonderTree will be showcasing its model for child and adolescent mental healthcare WonderTree founders Dr. Stephanie Lavoie (left) and Dr. Michelle Fardella (right) ORANGEVILLE, Ontario, Oct. 14, [...]

INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

14/10/2024 - 15:18

Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (“INVO”) (NASDAQ [...]

Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)

14/10/2024 - 15:05

MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its submission entitled “Lomecel-B inhibition of [...]

TytoCare and Frontier Health Partner to Provide Virtual-First Primary Care to Individuals and Employees across the United States

14/10/2024 - 15:00

New Partnership Will Provide TytoCare Devices to Thousands of Frontier Members across the U.S., Enabling In-Home Diagnostics and Extending Convenient Access to Relationship-Based Primary Care NEW YORK, Oct. 14, 2024 ( [...]

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

14/10/2024 - 14:31

Data selected for oral presentation reinforce previous findings on safety and efficacy MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing [...]

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

14/10/2024 - 14:30

Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency Stimulation (DIFS) technology for mental health treatment HOUSTON, TX, Oct. 14, 2024 ( [...]

Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit

14/10/2024 - 14:30

DOYLESTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic [...]

Novo Nordisk A/S - share repurchase programme

14/10/2024 - 14:06

Bagsværd, Denmark, 14 October 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

14/10/2024 - 14:00

Transition will Minimize Downtime, Deliver Faster, More Cost-Effective Results, and Improve Overall Safety and Productivity NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (" [...]

NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price

14/10/2024 - 14:00

BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company received a letter (the “Deficiency Letter”) from the [...]